In early 1990 Dr. Linus Pauling said having dinner with William Decker, a friend of Dr. Pauling and a financial contributor to the Linus Pauling Institute of Science and Medicine. During dinner Dr. Pauling said:
"If the ongoing experiments at the institute pan out, we will be able to eradicate heart disease by simply administering the proper nutrients, in the proper combination, at the proper dosage.
Mr. Decker was not shocked by Dr. Pauling & # 39; s statement because he had followed Dr. Pauling research into the cause of atherosclerosis over the previous years.
In 1966, at the age of 65, Linus Pauling gave a speech, he stated that he was married to live another fifteen years or so. Soon after, he received a letter from Irwin Stone who has been in the audience. Stone told Pauling that he could live another fifty years if he would start taking massive doses of vitamin C.
Given the early deaths of both parents, and his personal recovery from Bright 's disease through nutrition, the promise of good health through vitamins intrigued Pauling. So, he and his wife, Ava Helen, started taking large doses of vitamin C.
In 1967 Pauling started his research on Vitamin C at his laboratory at California at San Diego. While at UC San Diego Pauling proposed new biomedical field he called Orthomolecular Medicine. He explained that the right molecules in the right price will result in By orthomolecular medicine he mean therapy entailing variant concentrations of such low-toxicity substances as vitamin C and other vitamins which are normally found in the body and which are necessary to good health.
In 1970, Pauling & # 39; s book, Vitamin C and the Common Cold, was published. It quickly became a best seller and helped to energize the "health-food" movement.
It was becoming more difficult for Pauling to continue his nutritional research in University setting, so Pauling founded the Linus Pauling Institute of Science and Medicine (LPI) in 1973.
The LPI investigated the role of vitamin C in cancer, longevity, AIDS , and even mental disorders.
In 1986 Pauling published the book, How to Live Longer and Feel Better, which - once again - sung the praises of vitamin C and other vitamins and minerals.
He knew from animal studies that when the late 80 's and early 90' s, early 90 's, Pauling began studying the effect of vitamin C is low, blood vessels tend to also weak. He also knows that body part of vitamin chemotherapy in the lower incidence of cardiovascular disease and lower death rates. C in order to make collagen. If a person does not acquire vitamin C in their diet, they will not be able to make enough collagen to keep their arteries and veins strong and flexible.
Pauling theorized that the plaque that builds up on the inside of the body to repair the weakened blood vessel with whatever substance happened to be available (cholesterol, fibrinogen, calcium, etc.).
Plaque was just a symptom of another disease, ie Chronic Scurvy - an ongoing deficiency of sufficient vitamin C and other nutrients in the diet.
The medical profession reacted with skepticism. The research was headed by Dr. Rath, a German researcher who had done previous research on on the investment chemistry involved in the deposition of plaque. a sticky form of cholesterol called Lipoprotein A - Lp (a) for short.
This Lp (a) to License in the diet, Lp (a) binding sites on the inside of arteries are exposed. This allows Lp (a) to accumulate at these sites. The Linus Pauling Institute documented the exact chemistry involved in this reaction.
Ar in with the knowledge of how and why Lp (a) binds to our treaties, Pauling set out to reverse the process - to find a way to unbind the Lp (a). And in 1991, Pauling and Rath received a patent for their Lp (a) binding inhibitors. the agents act chemically to prevent the deposition of heart disease by stimulating the production of elastin (an elastic form of collagen), the protein necessary for maintaining healthy blood vessels .
In a paper published in 1992, Dr. Rath discussed that the amino acids L-lysine and L-proline competitively interfere with the binding of Lp (a) to constituents of the vascular wall and atherosclerotic lesions. (a) in the vascular wall. More importantly, optimum concentrations of L-lysine and L-proline could release deposited lipoprotein (a) and other atherogenic lipoproteins from the vascular wall. new therapeutic goal: The pharmaceutical, non-invasive reversal of existing CVD with nutritional supplements. [Rath, M. (1992) Reducing the Risk for Cardiovascular Disease with Nutritional Supplements, Journal of Orthomolecular Medicine, 7: 153-162.]
In a 1993 paper entitled, A New Era in Medicine, Dr. Rath said that heart patients in his nutritional studies were experiencing:
• Cessation of angina pectoris within one or two weeks
• Cessation of irregular heartbeat (arrhythmia) within days
• Cessation of shortness of breath
• Increase in physical and mental strength
The most important among these nutrients are vitamin C, vitamin E, niacin, lysine, proline, coenzyme Q10, carnitine as well as having minerals. Rath, as well as said nutritional restriction, we have a comparison with prescription drugs in the therapy of angina pectoris, arrhythmia, hypertension, heart failure as well as for the prevention of diabetic vascular disease and other forms of cardiovascular disease. [Rath M. (1993). A New Era in Medicine, Journal of Orthomolecular Med, 8: 134-135.]
On July 27, 1993 Drs. Pauling and Rath were granted their second US Patent No. 5230996 entitled, Use of Ascorbate and Tranexamic Acid Solution for Organ and Blood Vessel Treatment Prior to Transplantation.
1) The treatment of occlusive cardiovascular disease with the use of Vitamin C covalently linked with binding inhibitors which inhibit the binding of Lp (a) to blood vessel walls,
2) The prevention of atherosclerosis by the same method, and
3) Reducing the plaque on (or in) organs or blood vessels prior to transplantation.
The third use involves an aqueous solution of the Vitamin C, binding inhibitors, and antioxidants. The use of this solution and the atherosclerotic plaque deposits simply melt away leaving a clean and healthy organ or vessel for transplantation. solution is standard procedure in bypass operation because it ensures that the grafted blood vessel is free of plaque.
Linus Pauling died of prostate cancer on August 19, 1994 at the age of 93. Not long after his death, the Linus Pauling Institute was moved to Oregon State University. After the move, the LPI dismissed Dr. Rath and decided not to continued Dr Pauling & # 39; s research into heart disease or formulate a product based on his and Dr. Rath & # 39; s patents.
Mainstream medicine continues to refuse to acknowledge that diet and dietary supplements can not only help prevent heart disease but, in Dr. Pauling 's words, "can even cure it."
Copyright 2010 Ray Ellis
